Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Stennert, E; Jungehulsing, M
   Surgery of the salivary gland (including reconstructive facial surgery): Standard and quality assurance
   LARYNGO-RHINO-OTOLOGIE
   
   E. Stennert e M. Jungehulsing, "Surgery of the salivary gland (including reconstructive facial surgery): Standard and quality assurance", LARY RH OTO, 80, 2001, pp. S156-S197
2. Fink, JN; Wallis, WE; Haydock, DA
   Myasthenia gravis with thymoma is more common in the Maori and Pacific Island populations in New Zealand
   INTERNAL MEDICINE JOURNAL
   
   J.N. Fink et al., "Myasthenia gravis with thymoma is more common in the Maori and Pacific Island populations in New Zealand", INTERN M J, 31(4), 2001, pp. 206-210
3. Lang, K; Lehmann, P; Bolsen, K; Ruzicka, T; Fritsch, C
   Aminolevulinic acid: pharmacological profile and clinical indication
   EXPERT OPINION ON INVESTIGATIONAL DRUGS
   
   K. Lang et al., "Aminolevulinic acid: pharmacological profile and clinical indication", EXPERT OP I, 10(6), 2001, pp. 1139-1156
4. Gong, H; Hayashida, H; Kitaoka, T; Amemiya, T
   Ultrastructural study of primary lacrimal adenocarcinoma
   EUROPEAN JOURNAL OF OPHTHALMOLOGY
   
   H. Gong et al., "Ultrastructural study of primary lacrimal adenocarcinoma", EUR J OPTHA, 11(3), 2001, pp. 301-305
5. Baba, M; Nomoto, Y; Iyoda, A; Saito, H; Hiroshima, K; Shibuya, K; Haga, Y; Hoshino, H; Iizasa, T; Horiuchi, F; Fujisawa, T
   Cytomorphologic features characteristic of tumor stages of thymomas
   ONCOLOGY REPORTS
   
   M. Baba et al., "Cytomorphologic features characteristic of tumor stages of thymomas", ONCOL REP, 8(5), 2001, pp. 1139-1143
6. Hauptmann, S; Dietel, M
   Serous tumors of low malignant potential of the ovary-molecular pathology:part 2
   VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY
   
   S. Hauptmann e M. Dietel, "Serous tumors of low malignant potential of the ovary-molecular pathology:part 2", VIRCHOWS AR, 438(6), 2001, pp. 539-551
7. Tateyama, H; Takahashi, E; Saito, Y; Fukai, I; Fujii, Y; Niwa, H; Eimoto, T
   Histopathologic changes of thymoma preoperatively treated with corticosteroids
   VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY
   
   H. Tateyama et al., "Histopathologic changes of thymoma preoperatively treated with corticosteroids", VIRCHOWS AR, 438(3), 2001, pp. 238-247
8. Kumamoto, H; Kimi, K; Ooya, K
   Immunohistochemical analysis of apoptosis-related factors (Fas, Fas ligand, caspase-3 and single-stranded DNA) in ameloblastomas
   JOURNAL OF ORAL PATHOLOGY & MEDICINE
   
   H. Kumamoto et al., "Immunohistochemical analysis of apoptosis-related factors (Fas, Fas ligand, caspase-3 and single-stranded DNA) in ameloblastomas", J ORAL PATH, 30(10), 2001, pp. 596-602
9. Kenny-Moynihan, MB; DeRose, PB; Gal, AA; Chakraborty, H; Cohen, C
   Flow and image cytometry in thymic neoplasia - Correlation with clinical outcome
   ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY
   
   M.B. Kenny-Moynihan et al., "Flow and image cytometry in thymic neoplasia - Correlation with clinical outcome", ANAL QUAN C, 23(4), 2001, pp. 313-320
10. Zanetta, G; Rota, S; Chiari, S; Bonazzi, C; Bratina, G; Mangioni, C
    Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: A prospective study
    JOURNAL OF CLINICAL ONCOLOGY
    
    G. Zanetta et al., "Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: A prospective study", J CL ONCOL, 19(10), 2001, pp. 2658-2664
11. Halperin, R; Zehavi, S; Dar, P; Habler, L; Hadas, E; Bukovsky, I; Schneider, D
    Clinical and molecular comparison between borderline serous ovarian tumorsand advanced serous papillary ovarian carcinomas
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
    
    R. Halperin et al., "Clinical and molecular comparison between borderline serous ovarian tumorsand advanced serous papillary ovarian carcinomas", EUR J GYN O, 22(4), 2001, pp. 292-296
12. Karseladze, AI
    On the site of origin of epithelial tumors of the ovary
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
    
    A.I. Karseladze, "On the site of origin of epithelial tumors of the ovary", EUR J GYN O, 22(2), 2001, pp. 110-115
13. Kirkbride, P; Liu, FF; O'Sullivan, B; Payne, D; Warde, P; Gullane, P; Pintilie, M; Keane, TJ; Cummings, B
    Outcome of curative management of malignant tumours of the parotid gland
    JOURNAL OF OTOLARYNGOLOGY
    
    P. Kirkbride et al., "Outcome of curative management of malignant tumours of the parotid gland", J OTOLARYNG, 30(5), 2001, pp. 271-279
14. Zergeroglu, S; Aksakal, O; Demirturk, F; Gokmen, O
    Prognostic importance of the nucleolar organizer region score in ovarian epithelial tumors
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION
    
    S. Zergeroglu et al., "Prognostic importance of the nucleolar organizer region score in ovarian epithelial tumors", GYNECOL OBS, 51(1), 2001, pp. 60-63
15. Dachman, AH; Visweswaran, A; Battula, R; Jameel, S; Waggoner, SE
    Role of chest CT in the follow-up of ovarian adenocarcinoma
    AMERICAN JOURNAL OF ROENTGENOLOGY
    
    A.H. Dachman et al., "Role of chest CT in the follow-up of ovarian adenocarcinoma", AM J ROENTG, 176(3), 2001, pp. 701-705
16. Hekimgil, M; Hamulu, F; Cagirici, U; Karabulut, B; Ozgen, AG; Soydan, S; Yilmaz, C
    Small cell neuroendocrine carcinoma of the thymus complicated by Gushing'ssyndrome - Report of a 58-year-old woman with a 3-year history of hypertension
    PATHOLOGY RESEARCH AND PRACTICE
    
    M. Hekimgil et al., "Small cell neuroendocrine carcinoma of the thymus complicated by Gushing'ssyndrome - Report of a 58-year-old woman with a 3-year history of hypertension", PATH RES PR, 197(2), 2001, pp. 129-133
17. Levine, PH; Abou-Nassar, S; Mittal, K
    Extrauterine low-grade endometrial stromal sarcoma with florid endometrioid glandular differentiation
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
    
    P.H. Levine et al., "Extrauterine low-grade endometrial stromal sarcoma with florid endometrioid glandular differentiation", INT J GYN P, 20(4), 2001, pp. 395-398
18. Vang, R; Whitaker, BP; Farhood, AI; Silva, EG; Ro, JY; Deavers, MT
    Immunohistochemical analysis of clear cell carcinoma of the gynecologic tract
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
    
    R. Vang et al., "Immunohistochemical analysis of clear cell carcinoma of the gynecologic tract", INT J GYN P, 20(3), 2001, pp. 252-259
19. Gonzalez-Suarez, E; Samper, E; Ramirez, A; Flores, JM; Martin-Caballero, J; Jorcano, JL; Blasco, MA
    Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes
    EMBO JOURNAL
    
    E. Gonzalez-Suarez et al., "Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes", EMBO J, 20(11), 2001, pp. 2619-2630
20. Gurevich, P; Ben-Hur, H; Berman, V; Huszar, M; Tendler, Y; Zusman, I
    Expression of apoptosis and apoptosis-related proteins in microvessels of human ovarian epithelial tumors
    ANTICANCER RESEARCH
    
    P. Gurevich et al., "Expression of apoptosis and apoptosis-related proteins in microvessels of human ovarian epithelial tumors", ANTICANC R, 21(2B), 2001, pp. 1335-1338
21. Tuccari, G; Giuffre, G; Catalano, A; Lentini, M; Batolo, D
    Standardized AgNOR analysis in actinic keratosis
    AMERICAN JOURNAL OF DERMATOPATHOLOGY
    
    G. Tuccari et al., "Standardized AgNOR analysis in actinic keratosis", AM J DERMAT, 23(5), 2001, pp. 407-412
22. Pan, CC; Chen, WYK; Chiang, H
    Spindle cell and mixed spindle/lymphocytic thymomas - An integrated clinicopathologic and immunohistochemical study of 81 cases
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    
    C.C. Pan et al., "Spindle cell and mixed spindle/lymphocytic thymomas - An integrated clinicopathologic and immunohistochemical study of 81 cases", AM J SURG P, 25(1), 2001, pp. 111-120
23. Alvarez, AA; Moore, WF; Robboy, SJ; Bentley, RC; Gumbs, C; Futreal, PA; Berchuck, A
    K-ras mutations in Mullerian inclusion cysts associated with serous borderline tumors of the ovary
    GYNECOLOGIC ONCOLOGY
    
    A.A. Alvarez et al., "K-ras mutations in Mullerian inclusion cysts associated with serous borderline tumors of the ovary", GYNECOL ONC, 80(2), 2001, pp. 201-206
24. Schramm, VL; Imola, MJ
    Management of nasopharyngeal salivary gland malignancy
    LARYNGOSCOPE
    
    V.L. Schramm e M.J. Imola, "Management of nasopharyngeal salivary gland malignancy", LARYNGOSCOP, 111(9), 2001, pp. 1533-1544
25. Seracchioli, R; Venturoli, S; Colombo, FM; Govoni, F; Missiroli, S; Bagnoli, A
    Fertility and tumor recurrence rate after conservative laparoscopic management of young women with early-stage borderline ovarian tumors
    FERTILITY AND STERILITY
    
    R. Seracchioli et al., "Fertility and tumor recurrence rate after conservative laparoscopic management of young women with early-stage borderline ovarian tumors", FERT STERIL, 76(5), 2001, pp. 999-1004
26. Ellerbroek, SM; Halbleib, JM; Benavidez, M; Warmka, JK; Wattenberg, EV; Stack, MS; Hudson, LG
    Phosphatidylinositol 3-kinase activity in epidermal growth factor-stimulated matrix metalloproteinase-9 production and cell surface association
    CANCER RESEARCH
    
    S.M. Ellerbroek et al., "Phosphatidylinositol 3-kinase activity in epidermal growth factor-stimulated matrix metalloproteinase-9 production and cell surface association", CANCER RES, 61(5), 2001, pp. 1855-1861
27. Wu, R; Zhai, Y; Fearon, ER; Cho, KR
    Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas
    CANCER RESEARCH
    
    R. Wu et al., "Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas", CANCER RES, 61(22), 2001, pp. 8247-8255
28. Ortiz, BH; Ailawadi, M; Colitti, C; Muto, MG; Deavers, M; Silva, EG; Berkowitz, RS; Mok, SC; Gershenson, DM
    Second primary or recurrence? Comparative patterns of p53 and K-ras mutations suggest that serous borderline ovarian tumors and subsequent serous carcinomas are unrelated tumors
    CANCER RESEARCH
    
    B.H. Ortiz et al., "Second primary or recurrence? Comparative patterns of p53 and K-ras mutations suggest that serous borderline ovarian tumors and subsequent serous carcinomas are unrelated tumors", CANCER RES, 61(19), 2001, pp. 7264-7267
29. Saegusa, M; Machida, D; Okayasu, I
    Possible associations among expression of p14(ARF), p16(INK4a), p21(WAF1/CIP1), p27(KIP1), and p53 accumulation and the balance of apoptosis and cellproliferation in ovarian carcinomas
    CANCER
    
    M. Saegusa et al., "Possible associations among expression of p14(ARF), p16(INK4a), p21(WAF1/CIP1), p27(KIP1), and p53 accumulation and the balance of apoptosis and cellproliferation in ovarian carcinomas", CANCER, 92(5), 2001, pp. 1177-1189
30. van Haaften-Day, C; Shen, Y; Xu, FJ; Yu, YH; Berchuck, A; Havrilesky, LJ; de Bruijn, HWA; van der Zee, AGJ; Bast, RC; Hacker, NF
    OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markersfor epithelial ovarian carcinoma - A critical appraisal
    CANCER
    
    C. van Haaften-Day et al., "OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markersfor epithelial ovarian carcinoma - A critical appraisal", CANCER, 92(11), 2001, pp. 2837-2844
31. Ozaki, K; Enomoto, T; Yoshino, K; Fujita, M; Buzard, GS; Kawano, K; Yamasaki, M; Murata, Y
    Impaired FHIT expression characterizes serous ovarian carcinoma
    BRITISH JOURNAL OF CANCER
    
    K. Ozaki et al., "Impaired FHIT expression characterizes serous ovarian carcinoma", BR J CANC, 85(2), 2001, pp. 247-254
32. Gu, J; Roth, LM; Younger, C; Michael, H; Abdul-Karim, FW; Zhang, SB; Ulbright, TM; Eble, JN; Cheng, L
    Molecular evidence for the independent origin of extra-ovarian papillary serous tumors of low malignant potential
    JOURNAL OF THE NATIONAL CANCER INSTITUTE
    
    J. Gu et al., "Molecular evidence for the independent origin of extra-ovarian papillary serous tumors of low malignant potential", J NAT CANC, 93(15), 2001, pp. 1147-1152
33. Goldstein, NS; Bassi, D
    Cytokeratins 7, 17, and 20 reactivity in pancreatic and ampulla of vater adenocarcinomas - Percentage of positivity and distribution is affected by the cut-point threshold
    AJCP. American journal of clinical pathology
    
    N.S. Goldstein e D. Bassi, "Cytokeratins 7, 17, and 20 reactivity in pancreatic and ampulla of vater adenocarcinomas - Percentage of positivity and distribution is affected by the cut-point threshold", AM J CLIN P, 115(5), 2001, pp. 695-702
34. Trope, CG; Kristensen, G; Makar, A
    Surgery for borderline tumor of the ovary
    SEMINARS IN SURGICAL ONCOLOGY
    
    C.G. Trope et al., "Surgery for borderline tumor of the ovary", SEM SURG ON, 19(1), 2000, pp. 69-75
35. Mori, M; Kasai, T; Nakai, M; Sato, K; Takeuchi, H; Takai, Y; Kanematsu, N
    Dentinogenic ghost cell tumor: histologic aspects, immunohistochemistry, lectin binding profiles, and biophysical studies
    ORAL ONCOLOGY
    
    M. Mori et al., "Dentinogenic ghost cell tumor: histologic aspects, immunohistochemistry, lectin binding profiles, and biophysical studies", ORAL ONCOL, 36(1), 2000, pp. 134-143
36. Dowling, CR; Risbridger, GP
    The role of inhibins and activins in prostate cancer pathogenesis
    ENDOCRINE-RELATED CANCER
    
    C.R. Dowling e G.P. Risbridger, "The role of inhibins and activins in prostate cancer pathogenesis", ENDOCR-R CA, 7(4), 2000, pp. 243-256
37. Morita, K; Ono, Y; Fukui, H; Tomita, S; Ueda, Y; Terano, A; Fujimori, T
    Incidence of P53 and K-ras alterations in ovarian mucinous and serous tumors
    PATHOLOGY INTERNATIONAL
    
    K. Morita et al., "Incidence of P53 and K-ras alterations in ovarian mucinous and serous tumors", PATHOL INT, 50(3), 2000, pp. 219-223
38. Stefanidou, M; Tosca, A; Themelis, G; Vazgiouraki, E; Balas, C
    In vivo fluorescence kinetics and photodynamic therapy efficacy of delta-aminolevulinic acid-induced porphyrins in basal cell carcinomas and actinic keratoses; implications for optimization of photodynamic therapy
    EUROPEAN JOURNAL OF DERMATOLOGY
    
    M. Stefanidou et al., "In vivo fluorescence kinetics and photodynamic therapy efficacy of delta-aminolevulinic acid-induced porphyrins in basal cell carcinomas and actinic keratoses; implications for optimization of photodynamic therapy", EUR J DERM, 10(5), 2000, pp. 351-356
39. Tibiletti, MB; Sessa, F; Bernasconi, B; Cerutti, R; Broggi, B; Furlan, D; Acquati, F; Bianchi, M; Russo, A; Capella, C; Taramelli, R
    A large 6q deletion is a common cytogenetic alteration in fibroadenomas, pre-malignant lesions, and carcinomas of the breast
    CLINICAL CANCER RESEARCH
    
    M.B. Tibiletti et al., "A large 6q deletion is a common cytogenetic alteration in fibroadenomas, pre-malignant lesions, and carcinomas of the breast", CLIN CANC R, 6(4), 2000, pp. 1422-1431
40. Tamboli, P; Ro, JY; Amin, MB; Ligato, S; Ayala, AG
    Benign tumors and tumor-like lesions of the adult kidney part II: Benign mesenchymal and mixed neoplasms, and tumor-like lesions
    ADVANCES IN ANATOMIC PATHOLOGY
    
    P. Tamboli et al., "Benign tumors and tumor-like lesions of the adult kidney part II: Benign mesenchymal and mixed neoplasms, and tumor-like lesions", ADV ANAT PA, 7(1), 2000, pp. 47-66
41. Semczuk, A; Stenzel, A; Baranowski, W; Rozynska, K; Cybulski, M; Kostuch, M; Jakowicki, J; Wojcierowski, J
    Detection of human papillomavirus types 16 and 18 in human neoplastic endometrium: Lack of correlation with established prognostic factors
    ONCOLOGY REPORTS
    
    A. Semczuk et al., "Detection of human papillomavirus types 16 and 18 in human neoplastic endometrium: Lack of correlation with established prognostic factors", ONCOL REP, 7(4), 2000, pp. 905-910
42. Ng, SW; Yiu, GK; Liu, Y; Huang, LW; Palnati, M; Jun, SH; Berkowitz, RS; Mok, SC
    Analysis of p73 in human borderline and invasive ovarian tumor
    ONCOGENE
    
    S.W. Ng et al., "Analysis of p73 in human borderline and invasive ovarian tumor", ONCOGENE, 19(15), 2000, pp. 1885-1890
43. Dietel, M; Hauptmann, S
    Serous tumors of low malignant potential of the ovary 1. Diagnostic pathology
    VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY
    
    M. Dietel e S. Hauptmann, "Serous tumors of low malignant potential of the ovary 1. Diagnostic pathology", VIRCHOWS AR, 436(5), 2000, pp. 403-412
44. Takata, T; Zhao, M; Uchida, T; Kudo, Y; Sato, S; Nikai, H
    Immunohistochemical demonstration of an enamel sheath protein, sheathlin, in odontogenic tumors
    VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY
    
    T. Takata et al., "Immunohistochemical demonstration of an enamel sheath protein, sheathlin, in odontogenic tumors", VIRCHOWS AR, 436(4), 2000, pp. 324-329
45. Cao, Y; Karsten, U; Zerban, H; Bannasch, P
    Expression of MUC1, Thomsen-Friedenreich-related antigens, and cytokeratin19 in human renal cell carcinomas and tubular clear cell lesions
    VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY
    
    Y. Cao et al., "Expression of MUC1, Thomsen-Friedenreich-related antigens, and cytokeratin19 in human renal cell carcinomas and tubular clear cell lesions", VIRCHOWS AR, 436(2), 2000, pp. 119-126
46. Hattori, H; Tateyama, H; Tada, T; Saito, Y; Yamakawa, Y; Eimoto, T
    PE-35-related antigen expression and CD1a-positive lymphocytes in thymoma subtypes based on Muller-Hermelink classification - An immunohistochemical study using catalyzed signal amplification
    VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY
    
    H. Hattori et al., "PE-35-related antigen expression and CD1a-positive lymphocytes in thymoma subtypes based on Muller-Hermelink classification - An immunohistochemical study using catalyzed signal amplification", VIRCHOWS AR, 436(1), 2000, pp. 20-27
47. Engel, PJH
    Absence of latent Epstein-Barr virus in thymic epithelial tumors as demonstrated by Epstein-Barr-encoded RNA (EBER) in situ hybridization
    APMIS
    
    P.J.H. Engel, "Absence of latent Epstein-Barr virus in thymic epithelial tumors as demonstrated by Epstein-Barr-encoded RNA (EBER) in situ hybridization", APMIS, 108(6), 2000, pp. 393-397
48. Menzin, AW
    Update on low malignant potential ovarian tumors
    ONCOLOGY-NEW YORK
    
    A.W. Menzin, "Update on low malignant potential ovarian tumors", ONCOLOGY-NY, 14(6), 2000, pp. 897
49. Kawamura, K; Tanaka, T; Ikeda, R; Fujikawa-Yamamoto, K; Suzuki, K
    DNA ploidy analysis of urinary tract epithelial tumors by laser scanning cytometry
    ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY
    
    K. Kawamura et al., "DNA ploidy analysis of urinary tract epithelial tumors by laser scanning cytometry", ANAL QUAN C, 22(1), 2000, pp. 26-30
50. Piura, B; Rabinovich, A; Yanai-Inbar, I
    Micropapillary serous carcinoma of the ovary: Case report and review of literature
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
    
    B. Piura et al., "Micropapillary serous carcinoma of the ovary: Case report and review of literature", EUR J GYN O, 21(4), 2000, pp. 374-376
51. Ben-Hur, H; Gurevich, P; Huszar, M; Ben-Arie, A; Berman, V; Tendler, Y; Zinder, O; Tchanishev, R; Gershon, S; Mor, G; Zaltsman, Y; Kohen, F; Zusman, I
    Apoptosis and apoptosis-related proteins (Fas, Fas ligand, Blc-2, p53) in lymphoid elements of human ovarian tumors
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
    
    H. Ben-Hur et al., "Apoptosis and apoptosis-related proteins (Fas, Fas ligand, Blc-2, p53) in lymphoid elements of human ovarian tumors", EUR J GYN O, 21(1), 2000, pp. 53-57
52. Yoshikawa, H; Jimbo, H; Okada, S; Matsumoto, K; Onda, T; Yasugi, T; Taketani, Y
    Prevalence of endometriosis in ovarian cancer
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION
    
    H. Yoshikawa et al., "Prevalence of endometriosis in ovarian cancer", GYNECOL OBS, 50, 2000, pp. 11-15
53. Tanaka, YO; Yoshizako, T; Nishida, M; Yamaguchi, M; Sugimura, K; Itai, Y
    Ovarian carcinoma in patients with endometriosis: MR imaging findings
    AMERICAN JOURNAL OF ROENTGENOLOGY
    
    Y.O. Tanaka et al., "Ovarian carcinoma in patients with endometriosis: MR imaging findings", AM J ROENTG, 175(5), 2000, pp. 1423-1430
54. Kuo, T
    Frequent presence of neuroendocrine small cells in thymic carcinoma: a light microscopic and immunohistochemical study
    HISTOPATHOLOGY
    
    T. Kuo, "Frequent presence of neuroendocrine small cells in thymic carcinoma: a light microscopic and immunohistochemical study", HISTOPATHOL, 37(1), 2000, pp. 19-26
55. Kuo, T
    Cytokeratin profiles of the thymus and thymomas: histogenetic correlationsand proposal for a histological classification of thymomas
    HISTOPATHOLOGY
    
    T. Kuo, "Cytokeratin profiles of the thymus and thymomas: histogenetic correlationsand proposal for a histological classification of thymomas", HISTOPATHOL, 36(5), 2000, pp. 403-414
56. Bartel-Friedrich, S; Friedrich, RE; Holzhausen, HJ
    Expression of cytokeratins and additional markers in undifferentiated lymph node metastases of the neck
    ANTICANCER RESEARCH
    
    S. Bartel-Friedrich et al., "Expression of cytokeratins and additional markers in undifferentiated lymph node metastases of the neck", ANTICANC R, 20(6D), 2000, pp. 4931-4940
57. Buy, JN; Hugol, D; Ghossain, M; Vadrot, D
    Malignant tumors of the ovaries: role of imaging
    JOURNAL DE RADIOLOGIE
    
    J.N. Buy et al., "Malignant tumors of the ovaries: role of imaging", J RADIOLOG, 81(12), 2000, pp. 1833-1843
58. Christiansen, S; Marx, A; Kiefer, R; Scheld, HH; Semik, M
    Small thymomas and myasthenia gravis: a poorly understood association
    THORACIC AND CARDIOVASCULAR SURGEON
    
    S. Christiansen et al., "Small thymomas and myasthenia gravis: a poorly understood association", THOR CARD S, 48(2), 2000, pp. 109-111
59. Gripp, S; Hilgers, K; Ploem-Zaaijer, JJ; Hartmann, A; Schmitt, G
    Prognostic significance of DNA cytometry in thymoma
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    
    S. Gripp et al., "Prognostic significance of DNA cytometry in thymoma", J CANC RES, 126(5), 2000, pp. 280-284
60. Suzuki, M; Saito, S; Saga, Y; Ohwada, M; Sato, I
    Mutation of K-RAS protooncogene and loss of heterozygosity on 6q27 in serous and mucinous ovarian carcinomas
    CANCER GENETICS AND CYTOGENETICS
    
    M. Suzuki et al., "Mutation of K-RAS protooncogene and loss of heterozygosity on 6q27 in serous and mucinous ovarian carcinomas", CANC GENET, 118(2), 2000, pp. 132-135
61. Ohwada, M; Suzuki, M; Saga, Y; Sato, I
    DNA replication errors are frequent in mucinous cystadenocarcinoma of the ovary
    CANCER GENETICS AND CYTOGENETICS
    
    M. Ohwada et al., "DNA replication errors are frequent in mucinous cystadenocarcinoma of the ovary", CANC GENET, 117(1), 2000, pp. 61-65
62. Hishima, T; Fukayama, M; Hayashi, Y; Fujii, T; Ooba, T; Funata, N; Koike, M
    CD70 expression in thymic carcinoma
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    
    T. Hishima et al., "CD70 expression in thymic carcinoma", AM J SURG P, 24(5), 2000, pp. 742-746
63. Lee, KR; Scully, RE
    Mucinous tumors of the ovary - A clinicopathologic study of 196 borderlinetumors (of intestinal type) and carcinomas, including an evaluation of 11 cases with 'pseudomyxoma peritonei'
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    
    K.R. Lee e R.E. Scully, "Mucinous tumors of the ovary - A clinicopathologic study of 196 borderlinetumors (of intestinal type) and carcinomas, including an evaluation of 11 cases with 'pseudomyxoma peritonei'", AM J SURG P, 24(11), 2000, pp. 1447-1464
64. Bell, KA; Kurman, RJ
    A clinicopathologic analysis of atypical proliferative (borderline) tumorsand well-differentiated endometrioid adenocarcinomas of the ovary
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    
    K.A. Bell e R.J. Kurman, "A clinicopathologic analysis of atypical proliferative (borderline) tumorsand well-differentiated endometrioid adenocarcinomas of the ovary", AM J SURG P, 24(11), 2000, pp. 1465-1479
65. Schmitz, MJ; Hendricks, DT; Farley, J; Taylor, RR; Geradts, J; Rose, GS; Birrer, MJ
    P27 and cyclin D1 abnormalities in uterine papillary serous carcinoma
    GYNECOLOGIC ONCOLOGY
    
    M.J. Schmitz et al., "P27 and cyclin D1 abnormalities in uterine papillary serous carcinoma", GYNECOL ONC, 77(3), 2000, pp. 439-445
66. Garrett, AP; Ng, SW; Muto, MG; Welch, WR; Bell, DA; Berkowitz, RS; Mok, SC
    ras gene activation and infrequent mutation in papillary serous carcinoma of the peritoneum
    GYNECOLOGIC ONCOLOGY
    
    A.P. Garrett et al., "ras gene activation and infrequent mutation in papillary serous carcinoma of the peritoneum", GYNECOL ONC, 77(1), 2000, pp. 105-111
67. Timmins, PF; Kuo, DYS; Anderson, PS; Fields, AL; Whitney, KD; Goldberg, GL
    Ovarian carcinoid: Management of primary and recurrent tumors
    GYNECOLOGIC ONCOLOGY
    
    P.F. Timmins et al., "Ovarian carcinoid: Management of primary and recurrent tumors", GYNECOL ONC, 76(1), 2000, pp. 112-114
68. Palazzo, JP; Monzon, F; Burke, M; Hyslop, T; Dunton, C; Barusevicius, A; Capuzzi, D; Kovatich, AJ
    Overexpression of p21(WAF1/C1P1) and MDM2 characterizes serous borderline ovarian tumors
    HUMAN PATHOLOGY
    
    J.P. Palazzo et al., "Overexpression of p21(WAF1/C1P1) and MDM2 characterizes serous borderline ovarian tumors", HUMAN PATH, 31(6), 2000, pp. 698-704
69. Seidman, JD; Kurman, RJ
    Ovarian serous borderline tumors: A critical review of the literature withemphasis on prognostic indicators
    HUMAN PATHOLOGY
    
    J.D. Seidman e R.J. Kurman, "Ovarian serous borderline tumors: A critical review of the literature withemphasis on prognostic indicators", HUMAN PATH, 31(5), 2000, pp. 539-557
70. Izbicki, JR; Hosch, SB
    The significance of immunohistochemically detectable tumor cells in lymph nodes
    ZENTRALBLATT FUR CHIRURGIE
    
    J.R. Izbicki e S.B. Hosch, "The significance of immunohistochemically detectable tumor cells in lymph nodes", ZBL CHIR, 125(10), 2000, pp. 796-798
71. Mayerson, D; Rondini, C; Braun, H; Chuaqui, R; Branes, J
    Primary peritoneal serous tumor with potentially low malignancy. Report ofone case
    REVISTA MEDICA DE CHILE
    
    D. Mayerson et al., "Primary peritoneal serous tumor with potentially low malignancy. Report ofone case", REV MED CHI, 128(2), 2000, pp. 206-210
72. Morris, RT; Gershenson, DM; Silva, EG; Follen, M; Morris, M; Wharton, JT
    Outcome and reproductive function after conservative surgery for borderline ovarian tumors
    OBSTETRICS AND GYNECOLOGY
    
    R.T. Morris et al., "Outcome and reproductive function after conservative surgery for borderline ovarian tumors", OBSTET GYN, 95(4), 2000, pp. 541-547
73. Reino, AJ
    Factors in the pathogenesis of tumors of the sphenoid and maxillary sinuses: A comparative study
    LARYNGOSCOPE
    
    A.J. Reino, "Factors in the pathogenesis of tumors of the sphenoid and maxillary sinuses: A comparative study", LARYNGOSCOP, 110(10), 2000, pp. 1-38
74. Atit, RP; Mitchell, K; Nguyen, L; Warshawsky, D; Ratner, N
    The neurofibromatosis type 1 (Nf1) tumor suppressor is a modifier of carcinogen-induced pigmentation and papilloma formation in C57BL/6 mice
    JOURNAL OF INVESTIGATIVE DERMATOLOGY
    
    R.P. Atit et al., "The neurofibromatosis type 1 (Nf1) tumor suppressor is a modifier of carcinogen-induced pigmentation and papilloma formation in C57BL/6 mice", J INVES DER, 114(6), 2000, pp. 1093-1100
75. Ferone, D; van Hagen, MP; Kwekkeboom, DJ; van Koetsveld, PM; Mooy, DM; Lichtenauer-Kaligis, E; Schonbrunn, A; Colao, A; Lamberts, SWJ; Hofland, LJ
    Somatostatin receptor subtypes in human thymoma and inhibition of cell proliferation by octreotide in vitro
    JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    
    D. Ferone et al., "Somatostatin receptor subtypes in human thymoma and inhibition of cell proliferation by octreotide in vitro", J CLIN END, 85(4), 2000, pp. 1719-1726
76. Nomura, K; Aizawa, S
    Noninvasive, microinvasive, and invasive mucinous carcinomas of the ovary - A clinicopathologic analysis of 40 cases
    CANCER
    
    K. Nomura e S. Aizawa, "Noninvasive, microinvasive, and invasive mucinous carcinomas of the ovary - A clinicopathologic analysis of 40 cases", CANCER, 89(7), 2000, pp. 1541-1546
77. Hoffacker, V; Schultz, A; Tiesinga, JJ; Gold, R; Schalke, B; Nix, W; Kiefer, R; Muller-Hermelink, HK; Marx, A
    Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated autoimmune disease
    BLOOD
    
    V. Hoffacker et al., "Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated autoimmune disease", BLOOD, 96(12), 2000, pp. 3872-3879
78. Lardinois, D; Rechsteiner, R; Lang, H; Gugger, M; Betticher, D; von Briel, C; Krueger, T; Ris, HB
    Prognostic relevance of Masaoka and Muller-Hermelink classification in patients with thymic tumors
    ANNALS OF THORACIC SURGERY
    
    D. Lardinois et al., "Prognostic relevance of Masaoka and Muller-Hermelink classification in patients with thymic tumors", ANN THORAC, 69(5), 2000, pp. 1550-1555
79. Prat, J
    Ovarian tumors of borderline malignancy (tumors of low malignant potential): A critical appraisal
    ADVANCES IN ANATOMIC PATHOLOGY
    
    J. Prat, "Ovarian tumors of borderline malignancy (tumors of low malignant potential): A critical appraisal", ADV ANAT PA, 6(5), 1999, pp. 247-274
80. Loyer, EM; Whitman, GJ; Fenstermacher, MJ
    Imaging of ovarian carcinoma
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    
    E.M. Loyer et al., "Imaging of ovarian carcinoma", INT J GYN C, 9(5), 1999, pp. 351-361
81. Dunn, J; Garde, J; Dolan, K; Gosney, JR; Sutton, R; Meltzer, SJ; Field, JK
    Multiple target sites of allelic imbalance on chromosome 17 in Barrett's oesophageal cancer
    ONCOGENE
    
    J. Dunn et al., "Multiple target sites of allelic imbalance on chromosome 17 in Barrett's oesophageal cancer", ONCOGENE, 18(4), 1999, pp. 987-993
82. Haas, CJ; Diebold, J; Hirschmann, A; Rohrbach, H; Lohrs, U
    In serous ovarian neoplasms the frequency of Ki-ras mutations correlates with their malignant potential
    VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY
    
    C.J. Haas et al., "In serous ovarian neoplasms the frequency of Ki-ras mutations correlates with their malignant potential", VIRCHOWS AR, 434(2), 1999, pp. 117-120
83. Higaki, S; Tada, M; Nishiaki, M; Mitani, N; Yanai, H; Okita, K
    Immunohistological study to determine the presence of pericryptal myofibroblasts and basement membrane in colorectal epithelial tumors
    JOURNAL OF GASTROENTEROLOGY
    
    S. Higaki et al., "Immunohistological study to determine the presence of pericryptal myofibroblasts and basement membrane in colorectal epithelial tumors", J GASTRO, 34(2), 1999, pp. 215-220
84. Manek, S; Wells, M
    Pathology of borderline ovarian tumours
    CLINICAL ONCOLOGY
    
    S. Manek e M. Wells, "Pathology of borderline ovarian tumours", CL ONCOL-UK, 11(2), 1999, pp. 73-77
85. Terlikowski, S; Sulkowski, S; Lenczewski, A; Musiatowicz, B; Kulikowski, M
    Study of borderline and invasive mucinous ovarian tumors using Ki-67 (MIB 1) antibodies and nucleolar organizer region (NOR) staining
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS
    
    S. Terlikowski et al., "Study of borderline and invasive mucinous ovarian tumors using Ki-67 (MIB 1) antibodies and nucleolar organizer region (NOR) staining", ARCH GYN OB, 263(1-2), 1999, pp. 29-33
86. Muller-Hermelink, HK; Marx, A
    Pathological aspects of malignant and benign thymic disorders
    ANNALS OF MEDICINE
    
    H.K. Muller-Hermelink e A. Marx, "Pathological aspects of malignant and benign thymic disorders", ANN MED, 31, 1999, pp. 5-14
87. Ritter, JH; Wick, MR
    Primary carcinomas of the thymus gland
    SEMINARS IN DIAGNOSTIC PATHOLOGY
    
    J.H. Ritter e M.R. Wick, "Primary carcinomas of the thymus gland", SEM DIAGN P, 16(1), 1999, pp. 18-31
88. Gershenson, DM
    Contemporary treatment of borderline ovarian tumors
    CANCER INVESTIGATION
    
    D.M. Gershenson, "Contemporary treatment of borderline ovarian tumors", CANCER INV, 17(3), 1999, pp. 206-210
89. Darwish, AH; Al-Arrayedh, EA; Al-Khalifa, KA; Hameed, TH
    Surgical pathology of appendectomy specimens
    SAUDI MEDICAL JOURNAL
    
    A.H. Darwish et al., "Surgical pathology of appendectomy specimens", SAUDI MED J, 20(5), 1999, pp. 341-345
90. Schultz, A; Hoffacker, V; Wilisch, A; Nix, W; Gold, R; Schalke, B; Tzartos, S; Muller-Hermelink, HK; Marx, A
    Neurofilament is an autoantigenic determinant in myasthenia gravis
    ANNALS OF NEUROLOGY
    
    A. Schultz et al., "Neurofilament is an autoantigenic determinant in myasthenia gravis", ANN NEUROL, 46(2), 1999, pp. 167-175
91. Engel, P; Marx, A; Muller-Hermelink, HK
    Thymic tumours in Denmark - A retrospective study of 213 cases from 1970-1993
    PATHOLOGY RESEARCH AND PRACTICE
    
    P. Engel et al., "Thymic tumours in Denmark - A retrospective study of 213 cases from 1970-1993", PATH RES PR, 195(8), 1999, pp. 565-570
92. Gattenlohner, S; Muller-Hermelink, HK; Marx, A
    Transcription of the nude gene (WHN) in human normal organs and mediastinal and pulmonary tumors
    PATHOLOGY RESEARCH AND PRACTICE
    
    S. Gattenlohner et al., "Transcription of the nude gene (WHN) in human normal organs and mediastinal and pulmonary tumors", PATH RES PR, 195(8), 1999, pp. 571-574
93. Marienhagen, J; Schalke, B; Aebert, H; Held, P; Eilles, C; Bogdahn, U
    Somatostatin receptor scintigraphy in thymoma imaging method and clinical application
    PATHOLOGY RESEARCH AND PRACTICE
    
    J. Marienhagen et al., "Somatostatin receptor scintigraphy in thymoma imaging method and clinical application", PATH RES PR, 195(8), 1999, pp. 575-581
94. Gogusev, J; de Joliniere, JB; Telvi, L; Doussau, M; du Manoir, S; Stojkoski, A; Levardon, M
    Detection of DNA copy number changes in human endometriosis by comparativegenomic hybridization
    HUMAN GENETICS
    
    J. Gogusev et al., "Detection of DNA copy number changes in human endometriosis by comparativegenomic hybridization", HUM GENET, 105(5), 1999, pp. 444-451
95. Yoneda, S; Marx, A; Heimann, S; Shirakusa, T; Kikuchi, M; Muller-Hermelink, HK
    Low-grade metaplastic carcinoma of the thymus
    HISTOPATHOLOGY
    
    S. Yoneda et al., "Low-grade metaplastic carcinoma of the thymus", HISTOPATHOL, 35(1), 1999, pp. 19-30
96. Khunamornpong, S; Russell, P; Dalrymple, JC
    Proliferating (LMP) mucinous tumors of the ovaries with microinvasion: Morphologic assessment of 13 cases
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
    
    S. Khunamornpong et al., "Proliferating (LMP) mucinous tumors of the ovaries with microinvasion: Morphologic assessment of 13 cases", INT J GYN P, 18(3), 1999, pp. 238-246
97. Tworek, H; Peng, RQ; Fetzer, S; Werness, BA; Piver, MS; Allen, HJ; DiCioccio, RA
    Mutation analysis of BRCA1, TP53, and KRAS2 in ovarian and related pelvic tumors
    CANCER GENETICS AND CYTOGENETICS
    
    H. Tworek et al., "Mutation analysis of BRCA1, TP53, and KRAS2 in ovarian and related pelvic tumors", CANC GENET, 112(2), 1999, pp. 105-118
98. Ramos-Suzarte, M; Rodriguez, N; Oliva, JP; Iznaga-Escobar, N; Perera, A; Morales, A; Gonzalez, N; Cordero, M; Torres, L; Pimentel, G; Borron, M; Gonzalez, J; Torres, O; Rodriguez, T; Perez, R
    Tc-99m-labeled antihuman epidermal growth factor receptor antibody in patients with tumors of epithelial origin: Part III. Clinical trials safety anddiagnostic efficacy
    JOURNAL OF NUCLEAR MEDICINE
    
    M. Ramos-Suzarte et al., "Tc-99m-labeled antihuman epidermal growth factor receptor antibody in patients with tumors of epithelial origin: Part III. Clinical trials safety anddiagnostic efficacy", J NUCL MED, 40(5), 1999, pp. 768-775
99. Riopel, MA; Ronnett, BM; Kurman, RJ
    Evaluation of diagnostic criteria and behavior of ovarian intestinal-type mucinous tumors - Atypical proliferative (borderline) tumors and intraepithelial, microinvasive, invasive, and metastatic carcinomas
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    
    M.A. Riopel et al., "Evaluation of diagnostic criteria and behavior of ovarian intestinal-type mucinous tumors - Atypical proliferative (borderline) tumors and intraepithelial, microinvasive, invasive, and metastatic carcinomas", AM J SURG P, 23(6), 1999, pp. 617-635
100. Marx, A; Muller-Hermelink, HK
     Thymoma and thymic carcinoma
     AMERICAN JOURNAL OF SURGICAL PATHOLOGY
     
     A. Marx e H.K. Muller-Hermelink, "Thymoma and thymic carcinoma", AM J SURG P, 23(6), 1999, pp. 739-740